177 related articles for article (PubMed ID: 27824155)
1. Cucurbitacin D exhibits potent anti-cancer activity in cervical cancer.
Sikander M; Hafeez BB; Malik S; Alsayari A; Halaweish FT; Yallapu MM; Chauhan SC; Jaggi M
Sci Rep; 2016 Nov; 6():36594. PubMed ID: 27824155
[TBL] [Abstract][Full Text] [Related]
2. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
[TBL] [Abstract][Full Text] [Related]
3. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
4. [Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].
Liu T; Zhang M; Deng Y; Zhang H; Sun C; Yang X; Ji W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 May; 22(9):403-7. PubMed ID: 18652313
[TBL] [Abstract][Full Text] [Related]
5. A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.
Ming P; Cai T; Li J; Ning Y; Xie S; Tao T; Tang F
Oncotarget; 2016 Jul; 7(27):41843-41856. PubMed ID: 27259234
[TBL] [Abstract][Full Text] [Related]
6. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
[TBL] [Abstract][Full Text] [Related]
7. Targeted constitutive activation of signal transducer and activator of transcription 3 in human hepatocellular carcinoma cells by cucurbitacin B.
Zhang M; Zhang H; Sun C; Shan X; Yang X; Li-Ling J; Deng Y
Cancer Chemother Pharmacol; 2009 Mar; 63(4):635-42. PubMed ID: 18521604
[TBL] [Abstract][Full Text] [Related]
8. Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.
Munagala R; Kausar H; Munjal C; Gupta RC
Carcinogenesis; 2011 Nov; 32(11):1697-705. PubMed ID: 21859835
[TBL] [Abstract][Full Text] [Related]
9. 6r, a novel oxadiazole analogue of ethacrynic acid, exhibits antitumor activity both in vitro and in vivo by induction of cell apoptosis and S-phase arrest.
Zhang P; Chen JH; Dong X; Tang MT; Gao LY; Zhao GS; Yu LG; Guo XL
Biomed Pharmacother; 2013 Feb; 67(1):58-65. PubMed ID: 23201007
[TBL] [Abstract][Full Text] [Related]
10. Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer.
Liu T; Zhang M; Zhang H; Sun C; Yang X; Deng Y; Ji W
Eur J Pharmacol; 2008 Jun; 587(1-3):78-84. PubMed ID: 18442812
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.
Liu T; Peng H; Zhang M; Deng Y; Wu Z
Eur J Pharmacol; 2010 Sep; 641(1):15-22. PubMed ID: 20483353
[TBL] [Abstract][Full Text] [Related]
12. A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression.
Ahn WS; Huh SW; Bae SM; Lee IP; Lee JM; Namkoong SE; Kim CK; Sin JI
DNA Cell Biol; 2003 Mar; 22(3):217-24. PubMed ID: 12804120
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of cucurbitacin B in combination with curcumin via enhancing apoptosis induction and reversing multidrug resistance in human hepatoma cells.
Sun Y; Zhang J; Zhou J; Huang Z; Hu H; Qiao M; Zhao X; Chen D
Eur J Pharmacol; 2015 Dec; 768():28-40. PubMed ID: 26452516
[TBL] [Abstract][Full Text] [Related]
14. Cucurbitacin-I, a natural cell-permeable triterpenoid isolated from Cucurbitaceae, exerts potent anticancer effect in colon cancer.
Kim HJ; Park JH; Kim JK
Chem Biol Interact; 2014 Aug; 219():1-8. PubMed ID: 24858077
[TBL] [Abstract][Full Text] [Related]
15. VERU-111 suppresses tumor growth and metastatic phenotypes of cervical cancer cells through the activation of p53 signaling pathway.
Kashyap VK; Dan N; Chauhan N; Wang Q; Setua S; Nagesh PKB; Malik S; Batra V; Yallapu MM; Miller DD; Li W; Hafeez BB; Jaggi M; Chauhan SC
Cancer Lett; 2020 Feb; 470():64-74. PubMed ID: 31809801
[TBL] [Abstract][Full Text] [Related]
16. A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth.
Chauhan N; Maher DM; Yallapu MM; B Hafeez B; Singh MM; Chauhan SC; Jaggi M
Sci Rep; 2019 Jul; 9(1):10917. PubMed ID: 31358785
[TBL] [Abstract][Full Text] [Related]
17. miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.
Wen SY; Lin Y; Yu YQ; Cao SJ; Zhang R; Yang XM; Li J; Zhang YL; Wang YH; Ma MZ; Sun WW; Lou XL; Wang JH; Teng YC; Zhang ZG
Oncogene; 2015 Feb; 34(6):717-25. PubMed ID: 24608427
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration.
Chan KT; Meng FY; Li Q; Ho CY; Lam TS; To Y; Lee WH; Li M; Chu KH; Toh M
Cancer Lett; 2010 Aug; 294(1):118-24. PubMed ID: 20153103
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis induction through proteasome inhibitory activity of cucurbitacin D in human T-cell leukemia.
Ding N; Yamashita U; Matsuoka H; Sugiura T; Tsukada J; Noguchi J; Yoshida Y
Cancer; 2011 Jun; 117(12):2735-46. PubMed ID: 21656752
[TBL] [Abstract][Full Text] [Related]
20. Restoration of microRNA‑218 increases cellular chemosensitivity to cervical cancer by inhibiting cell‑cycle progression.
Dong R; Qiu H; Du G; Wang Y; Yu J; Mao C
Mol Med Rep; 2014 Dec; 10(6):3289-95. PubMed ID: 25310186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
